Compound 240
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C#N)c1c2[nH]n(-c2cccc(F)c2)c1=O
- InChi:
InChI=1S/C21H13FN6O/c1-27-20-16(11-24-27)19-17(18(25-20)13-5-2-4-12(8-13)10-23)21(29)28(26-19)15-7-3-6-14(22)9-15/h2-9,11,26H,1H3
- InChiKey:
MZBCNTIPBPFKKG-UHFFFAOYSA-N
External links
168318260 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 384.11 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 4.11 | |||
TPSA | 86.84 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4978 | Riociguat | DB08931 | |
0.4889 | Tepotinib | DB15133 | |
0.4813 | Vericiguat | DB15456 | |
0.4721 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4708 | ATX-914 | DB12673 | |
0.4522 | Dilmapimod | DB12140 | |
0.4480 | Merestinib | DB12381 | |
0.4444 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4362 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4358 | Risdiplam | DB15305 | |
0.4348 | Ravoxertinib | DB15281 | |
0.4342 | MK-6186 | DB12999 | |
0.4286 | Neflamapimod | DB07138 | |
0.4250 | ABT-288 | DB15192 | |
0.4233 | MK-0249 | DB11910 |